[4-(3,5-Dimethylpyridin-2-yl)piperazin-1-yl](4-iodophenyl)methanone → [4-(3,3-Dimethyl-1,1-dioxo-1lambda6-isothiazolidin-2-yl)phenyl][4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone
Reaction equation
[CH3:1][C:2]1([CH3:9])[CH2:6][CH2:5][S:4](=[O:8])(=[O:7])[NH:3]1.[CH3:10][C:11]1[C:12]([N:18]2[CH2:23][CH2:22][N:21]([C:24]([C:26]3[CH:31]=[CH:30][C:29](I)=[CH:28][CH:27]=3)=[O:25])[CH2:20][CH2:19]2)=[N:13][CH:14]=[C:15]([CH3:17])[CH:16]=1>>[CH3:1][C:2]1([CH3:9])[CH2:6][CH2:5][S:4](=[O:8])(=[O:7])[N:3]1[C:29]1[CH:30]=[CH:31][C:26]([C:24]([N:21]2[CH2:22][CH2:23][N:18]([C:12]3[C:11]([CH3:10])=[CH:16][C:15]([CH3:17])=[CH:14][N:13]=3)[CH2:19][CH2:20]2)=[O:25])=[CH:27][CH:28]=1Participants
3
Procedure
Using 3,3-dimethylisothiazolidine 1,1-dioxide (130 mg) described in Preparation Example 11 and [4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl](4-iodophenyl)methanone (367 mg) described in Preparation Example 113 and by the reaction and treatment in the same manner as in Example 1, the title compound (4.9 mg) was obtained.
Workup
- customdescribed in Preparation Example 113 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-1d8430379d524afb9a58432a691c3bac
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…